デジタルワクチン市場規模、シェア、成長分析：タイプ別、展開モード別、エンドユーザー別、地域別 - 産業予測 2025～2032年

デジタルワクチンの世界市場規模は、2023年に20億米ドルと評価され、2024年の22億2,000万米ドルから2032年には50億3,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは10.8％で成長する見通しです。

デジタルワクチンは、神経認知トレーニングやナッジング技術を通じて行動パターンを修正することで、心身の健康を促進する変革的なアプローチです。バーチャルリアリティ、スマートフォンアプリ、人工知能などの高度なデジタル技術を活用したこれらのツールは、前向きな習慣を育み、手頃な価格で効果的にメンタルヘルスを改善することを目的としています。ヘルスケアIT市場の急速な拡大は、モノのインターネット、ウェアラブル技術、AR/VRのような技術革新と並んで、様々な健康課題への頻繁な行動介入の提供を強化しています。米国国防総省のバーチャルPTSD体験のような取り組みは、メンタルヘルスケアにおけるバーチャルリアリティの可能性を例証しています。AIと機械学習が魅力的なアプリケーションの開発を推進する中、デジタルワクチンは、特に若者の間で、より健康的なライフスタイルを育成する上で有望視されています。このような技術革新の将来的なインパクトは、広大かつ有望です。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

デジタルワクチン市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• ワクチン管理ソフトウェア
• ワクチン接種追跡アプリケーション
• デジタルプラットフォーム

デジタルワクチン市場規模：展開モード別& CAGR（2025-2032）

• 市場概要
• クラウドベース
• オンプレミス

デジタルワクチン市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• ヘルスケア提供者
• 製薬・バイオテクノロジー企業
• 政府・公衆衛生機関
• 調査機関・学術センター
• 患者と介護者

デジタルワクチン市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Pfizer（US）
• Moderna（US）
• Johnson & Johnson（US）
• AstraZeneca（UK）
• Merck（US）
• Sanofi（France）
• GSK（UK）
• Novavax（US）
• BioNTech（Germany）
• Bharat Biotech（India）
• Microsoft（US）
• IBM（US）
• Oracle（US）
• Salesforce（US）
• Amazon（US）
• Google（US）
• McKesson（US）
• AmerisourceBergen（US）
• CVS Health（US）
• Walgreens Boots Alliance（US）

結論と提言

Global Digital Vaccine Market size was valued at USD 2.0 billion in 2023 and is poised to grow from USD 2.22 billion in 2024 to USD 5.03 billion by 2032, growing at a CAGR of 10.8% during the forecast period (2025-2032).

Digital vaccines represent a transformative approach to promoting mental and physical well-being by modifying behavioral patterns through neurocognitive training and nudging techniques. Utilizing advanced digital technologies such as virtual reality, smartphone apps, and artificial intelligence, these tools aim to foster positive habits and improve mental health affordably and effectively. The rapid expansion of the healthcare IT market, alongside innovations like the Internet of Things, wearable tech, and AR/VR, enhances the delivery of frequent behavioral interventions across various health challenges. Initiatives like the US Department of Defense's Virtual PTSD Experience exemplify the potential of virtual reality in mental health care. With AI and machine learning driving the development of engaging applications, digital vaccines hold promise in cultivating healthier lifestyles, particularly among youth. The future impact of these innovations is both vast and promising.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Vaccine Market Segments Analysis

Global Digital Vaccine Market is segmented by Type, Deployment mode, End user and region. Based on Type, the market is segmented into Vaccine management software, vaccination tracking applications and digital platforms. Based on Deployment mode, the market is segmented into Cloud-based and on-premise. Based on End user, the market is segmented into Healthcare providers, pharmaceutical & biotechnology companies, government & public health agencies, research institutes & academic centers and patients & caregivers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Digital Vaccine Market

The Global Digital Vaccine market is being significantly driven by a growing emphasis on immunization programs from governments and healthcare organizations across the globe, aimed at curtailing the spread of infectious diseases. This increased focus has spurred a demand for digital vaccine solutions to boost the efficiency and effectiveness of vaccination initiatives. For instance, the World Health Organization's Global Vaccine Action Plan strives to enhance vaccination coverage while ensuring equitable access to vaccines. Digital tools, such as mobile applications for scheduling appointments and sending reminders, empower healthcare providers to better connect with target populations, ultimately leading to improved vaccination rates and health outcomes.

Restraints in the Global Digital Vaccine Market

The Global Digital Vaccine market faces significant constraints related to the collection, storage, and sharing of sensitive health data within digital vaccination systems, which raises important issues surrounding data privacy and security. Ensuring the protection of personal health information and confidentiality of vaccination records is vital. The absence of effective security measures could lead to data breaches and unauthorized access, which can undermine public trust. Therefore, it is imperative to address these privacy concerns and adopt stringent data protection protocols to foster confidence and promote the widespread acceptance and use of digital vaccine solutions in the market.

Market Trends of the Global Digital Vaccine Market

The Global Digital Vaccine market is experiencing a notable trend towards integrating blockchain technology to enhance the security and transparency of vaccine supply chains. As stakeholders increasingly seek to combat counterfeit products and ensure the integrity and proper handling of vaccines, blockchain's decentralized and tamper-resistant ledger system emerges as a robust solution. Initiatives such as IBM's "Blockchain for Vaccines" showcase the potential of this technology to track vaccines from manufacturer to patient, providing clear traceability and auditability. This shift not only addresses the pressing concerns of vaccine integrity but also bolsters consumer confidence and supports streamlined operations within the healthcare sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Digital Vaccine Market Size by Type & CAGR (2025-2032)

• Market Overview
• Vaccine management software
• vaccination tracking applications
• digital platforms

Global Digital Vaccine Market Size by Deployment mode & CAGR (2025-2032)

• Market Overview
• Cloud-based
• on-premise

Global Digital Vaccine Market Size by End user & CAGR (2025-2032)

• Market Overview
• Healthcare providers
• pharmaceutical & biotechnology companies
• government & public health agencies
• research institutes & academic centers
• patients & caregivers

Global Digital Vaccine Market Size & CAGR (2025-2032)

• North America (Type, Deployment mode, End user)
  • US
  • Canada
• Europe (Type, Deployment mode, End user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Deployment mode, End user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Deployment mode, End user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Deployment mode, End user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Pfizer (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moderna (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GSK (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novavax (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioNTech (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microsoft (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Salesforce (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amazon (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Google (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AmerisourceBergen (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CVS Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Walgreens Boots Alliance (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations